A recent study found that the status of TP53 (wild/mutant) influences macrophages infiltration in six types of cancer, including uterine carcinosarcoma (UCS), OC, low grade glioma (LGG), stomach adenocarcinoma (STAD), liver hepatocellular carcinoma (LIHC), and uterine corpus endometrial carcinoma (UCEC). Here, TP53 is linked to cancer.